Effect of foot-and-mouth disease virus capsid precursor protein and 3C protease expression on bovine herpesvirus 1 replication

Archives of Virology

Volumn 155, Issue 5, 2010, Pages 723-731

  Klopfleisch, Constanze ^a   Minh, Luu Quang ^a   Giesow, Katrin ^a   Curry, Stephen ^b   Keil, Günther M ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3C PROTEASES; CAPSID PROTEIN; CYSTEINE PROTEINASE; HYBRID PROTEIN; PROTEIN PRECURSOR; VIRUS PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BOVINE HERPES VIRUS; CATTLE; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; GENE VECTOR; GENETICS; HAMSTER; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CATTLE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CRICETINAE; CYSTEINE ENDOPEPTIDASES; GENETIC VECTORS; HERPESVIRUS 1, BOVINE; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

BOVINE HERPESVIRUS 1; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN HERPESVIRUS 1; MIRIDAE;

EID: 77951977241     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0648-6     Document Type: Article

References (45)

1. Birtley JR, Knox SR, Jaulent AM, Brick P, Leatherbarrow RJ, Curry S (2005) Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J Biol Chem 280: 11520-11527.
2. Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ (2003) Engineering better vaccines for foot-and-mouth disease. Dev Biol 114: 79-88.
3. van Oirschot JT (1999) Diva vaccines that reduce virus transmission. J Biotechnol 73: 195-205.
4. Mingxiao M, Ningyi J, Juan LH, Min Z, Guoshun S, Guangze Z, Huijun L, Xiaowei H, Minglan J, Xu L, Haili M, Yue J, Gefen Y, Kuoshi J (2007) Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18. Antiviral Res 76: 59-67.
5. Doel TR, Chong WKT (1982) Comparative immunogenicity of 146S, 75S, and 12S particles of foot-and-mouth disease virus. Arch Virol 73: 185-191.
6. Rweyemamu MM, Terry G, Pay TWF (1979) Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol 59: 69-79.
7. Benvenisti L, Rogel A, Kuznetzova L, Bujanover S, Becker Y, Stram Y (2001) Gene gun-mediated DNA vaccination against foot-and-mouth disease virus. Vaccine 19: 3885-3895.
8. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ (1998) Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 72: 4454-4457.
9. Li Y, Aggarwal N, Takamatsu HH, Sterling CM, Voyce C, Barnett PV (2006) Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 24: 4602-4606.
10. Mayr GA, Chinsangaram J, Grubman MJ (1999) Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263: 496-506.
11. Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q (2006) Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. J Virol Methods 136: 230-237.
12. Frimann TH, Barfoed AM, Aasted B, Kamstrup S (2007) Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus-importance of dominant and subdominant epitopes for antigenicity and protection. Vaccine 25: 6191-6200.
13. Xiao C, Jin H, Hu Y, Kang Y, Wang J, Du X, Yang Y, She R, Wang B (2007) Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. Antiviral Res 76: 11-20.
14. Moraes M, Mayr GA, Mason PW, Grubman MJ (2002) Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20: 1631-1639.
15. Pacheco JM, Brum MC, Moraes MP, Golde WT, Grubman MJ (2005) Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337: 205-209.
16. McLean CS, Erturk M, Jennings R, Challanain DN, Minson AC, Duncan I, Boursnell ME, Inglis SC (1994) Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis 170: 1100-1109.
17. De Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, Golde WT, Grubman MJ (2006) Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24: 3446-3456.
18. Moraes MP, Chinsangaram J, Brum MC, Grubman MJ (2003) Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22: 268-279.
19. Höhle C, Karger A, König P, Giesow K, Keil GM (2005) High-level expression of biologically active bovine alpha interferon by Bovine herpesvirus 1 interferes only marginally with recombinant virus replication in vitro. J Gen Virol 86: 2685-2695.
20. Kühnle G, Collins RA, Scott JE, Keil GM (1996) Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins. J Gen Virol 77: 2231-2240.
21. König P, Beer M, Makoschey B, Teifke JP, Polster U, Giesow K, Keil GM (2003) Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain. Vaccine 22: 202-212.
22. Raggo C, Fitzpatrick DR, Babiuk LA, Liang X (1996) Expression of bovine interleukin-1 beta in a bovine herpesvirus-1 vector: in vitro analysis. Virology 221: 78-86.
23. Raggo C, Habermehl M, Babiuk LA, Griebel P (2000) The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. J Gen Virol 81: 2665-2673.
24. Schmitt J, Becher P, Thiel HJ, Keil GM (1999) Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions. J Gen Virol 80: 2839-2848.
25. Taylor G, Rijsewijk FA, Thomas LH, Wyld SG, Gaddum RM, Cook RS, Morrison WI, Hensen E, van Oirschot JT, Keil GM (1998) Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV. J Gen Virol 79: 1759-1767.
26. MacLachlan NJ, Rosenquist BD (1982) Duration of protection of calves against rhinovirus challenge exposure by infectious bovine rhinotracheitis virus-induced interferon in nasal secretions. Am J Vet Res 43: 289-293.
27. Straub C, Ahl R (1976) Local interferon production in cattle after intranasal infection with avirulent IBR/IPV virus and its effect on a subsequent infection with foot-and-mouth disease virus. Zentralbl Veterinärmed B 23: 470-482.
28. Todd JD, Volenec FJ, Paton IM (1972) Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect Immun 5: 699-706.
29. Mayr GA, O'Donnell V, Chinsangaram J, Mason PW, Grubman MJ (2001) Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19: 2152-2162.
30. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor.
31. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79: 6487-6504.
32. Rodríguez A, Dopazo J, Sáiz JC, Sobrino F (1994) Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol 136: 123-131.
33. Fehler F, Herrmann JM, Saalmüller A, Mettenleiter TC, Keil GM (1992) Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J Virol 66: 831-839.
34. Keil GM, Höhle C, Giesow K, König P (2005) Engineering glycoprotein B of bovine herpesvirus 1 to function as transporter for secreted proteins: a new protein expression approach. J Virol 79: 791-799.
35. Rauh I, Mettenleiter TC (1991) Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol 65: 5348-5356.
36. Rowlands DJ, Sangar DV, Brown F (1975) A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J Gen Virol 26: 227-238.
37. Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME (1995) Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 213: 581-589.
38. Sibanda BL, Blundell TL, Thornton JM (1989) Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J Mol Biol 206: 759-777.
39. Sweeney TR, Roqué-Rosell N, Birtley JR, Leatherbarrow RJ, Curry S (2007) Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the beta-ribbon in proteolysis. J Virol 81: 115-124.
40. Falk MM, Grigera PR, Bergmann IE, Zibert A, Multhaup G, Beck E (1990) Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol 64: 748-756.
41. Strong R, Belsham GJ (2004) Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3Cpro cleavage site. J Gen Virol 85: 2953-2962.
42. Engels M, Giuliani C, Wild P, Beck TM, Loepfe E, Wyler R (1986) The genome of bovine herpesvirus 1 (BHV-1) strains exhibiting a neuropathogenic potential compared to known BHV-1 strains by restriction site mapping and cross-hybridization. Virus Res 6: 57-73.
43. Mayfield JE, Good PJ, VanOort HJ, Campbell AR, Reed DE (1983) Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain). J Virol 47: 259-264.
44. Leung-Tack P, Audonnet JC, Riviere M (1994) The complete DNA sequence and the genetic organization of the short unique region (US) of the bovine herpesvirus type 1 (ST strain). Virology 199: 409-421.
45. Dorsch-Häsler K, Keil GM, Weber F, Jasin M, Schaffner W, Koszinowski UH (1985) A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci USA 82: 8325-8329.